DK200289A - Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et immunosuppresivt virksomt farmaceutisk praeparat - Google Patents

Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et immunosuppresivt virksomt farmaceutisk praeparat Download PDF

Info

Publication number
DK200289A
DK200289A DK200289A DK200289A DK200289A DK 200289 A DK200289 A DK 200289A DK 200289 A DK200289 A DK 200289A DK 200289 A DK200289 A DK 200289A DK 200289 A DK200289 A DK 200289A
Authority
DK
Denmark
Prior art keywords
preparation
pharmaceutical
acid derivative
suitable salt
immunosuppressive effective
Prior art date
Application number
DK200289A
Other languages
English (en)
Other versions
DK200289D0 (da
DK170414B1 (da
Inventor
Neil Richard Ackerman
Bruce Donald Jaffee
Scott Edward Loveless
Russell Howard Neubauer
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of DK200289D0 publication Critical patent/DK200289D0/da
Publication of DK200289A publication Critical patent/DK200289A/da
Application granted granted Critical
Publication of DK170414B1 publication Critical patent/DK170414B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK200289A 1988-04-26 1989-04-25 Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af farmaceutiske præparater DK170414B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/186,243 US4968701A (en) 1988-04-26 1988-04-26 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents
US18624388 1988-04-26

Publications (3)

Publication Number Publication Date
DK200289D0 DK200289D0 (da) 1989-04-25
DK200289A true DK200289A (da) 1989-10-27
DK170414B1 DK170414B1 (da) 1995-08-28

Family

ID=22684181

Family Applications (1)

Application Number Title Priority Date Filing Date
DK200289A DK170414B1 (da) 1988-04-26 1989-04-25 Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af farmaceutiske præparater

Country Status (13)

Country Link
US (1) US4968701A (da)
EP (1) EP0339485B1 (da)
JP (1) JP2650757B2 (da)
KR (1) KR0134376B1 (da)
AT (1) ATE87480T1 (da)
CA (1) CA1333155C (da)
DE (1) DE68905642T2 (da)
DK (1) DK170414B1 (da)
IE (1) IE64760B1 (da)
IL (1) IL90055A (da)
MY (1) MY106038A (da)
PT (1) PT90363B (da)
ZA (1) ZA893087B (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202005021811U1 (de) 2004-09-27 2010-04-15 Novozymes A/S Körnchen mit einem Kern und einer Beschichtung

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102883A (en) * 1989-10-31 1992-04-07 Du Pont Merck Pharmaceutical Company Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
US5204329A (en) * 1990-06-11 1993-04-20 Du Pont Merck Pharmaceutical Company Treatment of organ transplantation rejection
US5135934A (en) * 1990-07-06 1992-08-04 Du Pont Merck Pharmaceutical Company 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents
US6004979A (en) * 1991-02-07 1999-12-21 Hoechst Marion Roussel Nitrogenous bicycles
MX9200299A (es) * 1991-02-07 1992-12-01 Roussel Uclaf Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
US6077823A (en) * 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
US6194376B1 (en) 1991-03-11 2001-02-27 Creative Biomolecules, Inc. Method for modulating inflammatory response comprising administering morphogen
TW232013B (da) * 1992-04-24 1994-10-11 Takeda Pharm Industry Co Ltd
US5409886A (en) * 1993-02-18 1995-04-25 Mitsui Toatsu Chemicals, Incorporated 3-pyrroline-2-one derivatives and herbicidal compositions containing same
US5428040A (en) * 1993-08-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
US5578609A (en) * 1994-03-25 1996-11-26 The Dupont Merck Pharmaceutical Company 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
AU715358B2 (en) * 1995-04-28 2000-01-20 Takeda Chemical Industries Ltd. Therapeutic composition for arthritis
AU2896097A (en) * 1996-05-10 1997-12-05 Novartis Ag Use of brequinar and derivatives in chronic rejection of allografts and xenotransplantation
DK0825186T3 (da) * 1996-08-16 2002-07-22 Pfizer 2-aminobenzazepinderivater og deres anvendelse til behandling af immunosuppression
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
WO1998057931A2 (en) 1997-06-19 1998-12-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
AU2108099A (en) * 1998-01-30 1999-08-16 Procept, Inc. Immunosuppressive agents
EP3071199A2 (en) 2013-11-22 2016-09-28 Genzyme Corporation Novel methods for treating neurodegenerative diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6592M (da) * 1967-10-31 1968-12-30
GB1334705A (en) * 1970-06-19 1973-10-24 Ici Ltd Pharmaceutical compositions containing kynurenic acid derivatives
CH567477A5 (da) * 1972-03-10 1975-10-15 Ciba Geigy Ag
US4407803A (en) * 1981-08-17 1983-10-04 Abbott Laboratories Antiinflammatory 1-(quinolinyl)-2-pyrazoline derivatives
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
US4847381A (en) * 1987-08-31 1989-07-11 American Cyanamid Company 2-Phenyl-4-quinoline carboxylic acids

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202005021811U1 (de) 2004-09-27 2010-04-15 Novozymes A/S Körnchen mit einem Kern und einer Beschichtung
DE202005021810U1 (de) 2004-09-27 2010-04-22 Novozymes A/S Körnchen mit einem Kern und einer Beschichtung

Also Published As

Publication number Publication date
DK200289D0 (da) 1989-04-25
US4968701A (en) 1990-11-06
DK170414B1 (da) 1995-08-28
JP2650757B2 (ja) 1997-09-03
ATE87480T1 (de) 1993-04-15
ZA893087B (en) 1990-12-28
EP0339485A1 (en) 1989-11-02
AU628045B2 (en) 1992-09-10
PT90363B (pt) 1994-08-31
IL90055A0 (en) 1989-12-15
CA1333155C (en) 1994-11-22
DE68905642D1 (de) 1993-05-06
JPH01313428A (ja) 1989-12-18
DE68905642T2 (de) 1993-08-12
KR900016137A (ko) 1990-11-12
PT90363A (pt) 1989-11-10
IE891328L (en) 1989-10-26
IL90055A (en) 1993-05-13
KR0134376B1 (ko) 1998-04-21
EP0339485B1 (en) 1993-03-31
IE64760B1 (en) 1995-09-06
AU3332189A (en) 1989-11-02
MY106038A (en) 1994-03-31

Similar Documents

Publication Publication Date Title
DK200289A (da) Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et immunosuppresivt virksomt farmaceutisk praeparat
DK653688A (da) Stabiliserede laegemiddelaktive forbindelser, fremgangsmaade til deres frmstilling samt stabile laegemiddelpraeparater
NO883073L (no) 3-desmetyl-mevalonsyrederivater, fremgangsmaate for fremstilling av dem, farmasoeytiske preparater paa basis av disse forbindelsene, deres anvendelse saavel som mellomprodukter.
PT87474A (pt) Process for the preparation of pharmaceutical compounds which contain ester 1-acetoxi-ethylic of cefuroxime
DK39082A (da) Aromatiske heterocycliske estre af steroider,fremgangsmaade til deres fremstilling samt deres anvendelse
EP0936217A4 (en) 1-PHENYLPYROZOL COMPOUNDS AND THEIR MEDICAL APPLICATION
ATE50255T1 (de) Substituierte 9-fluor-3-methyl-7-oxo-2,3-dihydro7h-pyrido(1,2,3-de>(1,4>benzoxazin-6-carbonsaeur ; substituierte 5-amino-6-fluor-1,4-dihydro-4-oxochinolin-3-carbons|ure; substituierte 5-amino-6fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3- carbonsaeure; ihre derivate; diese enthaltende pharmazeutische zubereitungen und verfahren
SE7903186L (sv) Cerebralverksamt medel
NO883506D0 (no) Fremgangsmaate for fremstilling av foretrede polyoksyalkylenderivater.
DK644388D0 (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
DK199789A (da) Anvendelse af et phenylquinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et topisk farmaceutisk praeparat til behandling af hud- og/eller slimepithelsygdomme
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
NO883074D0 (no) Fremgangsmaate til fremstilling av 3-desmetyl-4-fluor-mevalonsyrederivater.
FI913131A0 (fi) Nya 3,3'-ditiobis (propionsyror)och deras estrar.
FI920018A7 (fi) Menetelmä 3-eksometyleenikefaamisulfoksidiestereiden valmistamiseksi
IT1197516B (it) Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
ATE86974T1 (de) (2-cyan-2-oximinoacetyl)-aminosaeure-derivate.
FI925546A7 (fi) Amidiliittyneitä pyridyylihappojohdannaisia leukotrieeniin liittyvien sairauksien hoitamiseksi
FI880385A0 (fi) Substituerade 3-fenyl-7h-tiazolo /3,2-b//1,2,4/-triazin-7-oner, foerfaranden foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning, samt naogra vid framstaellningen av naemnda foereningar bildade mellanprodukter.
ITMI920539A0 (it) Procedimento per la separazione dell'acido ftalimmido perossicaproico da soluzioni di solventi organici
WO1987004435A3 (en) Xanthine compounds
DK0440100T3 (da) Anvendelse af et galdesyresalt og et lipid
IT8720701A0 (it) Composizioni farmaceutiche adattivita' immunomodulante.
DK163432C (da) Analogifremgangsmaade til fremstilling af oe1,2,4aatriazolo-oe4,3-aaaquinoxalin-4-amin-derivater eller farmaceutisk acceptable syreadditionssalte deraf
IT8719949A0 (it) Composizioni farmaceutiche adattivita' immunomodulante.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed